Acro Biomedical Co., Ltd.

ACBM · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$0$0$6$95
Short-Term Investments$0$0$0$0
Receivables$0$0$639$598
Inventory$0$0$12$12
Other Curr. Assets$5$1$1$1
Total Curr. Assets$5$2$658$706
Property Plant & Equip (Net)$27$52$26$50
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$5$4$4
Total NC Assets$27$57$30$55
Other Assets$0$0$0$0
Total Assets$32$58$687$761
Liabilities
Payables$154$154$77$26
Short-Term Debt$54$25$26$25
Tax Payable$0$0$0$0
Deferred Revenue$20$20$20$20
Other Curr. Liab.$99$89$79$21
Total Curr. Liab.$327$289$201$92
LT Debt$0$27$0$26
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$27$0$26
Other Liabilities$0$0$0$0
Cap. Leases$27$52$26$50
Total Liabilities$327$315$201$117
Equity
Pref Stock$0$0$8,061$0
Common Stock$60$60$60$60
Retained Earnings-$32,658-$32,615-$23,808-$7,936
AOCI$0$0-$8,061-$23,773
Other Equity$32,303$32,298$24,234$32,294
Total Equity-$295-$257$486$644
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$32$58$687$761
Net Debt$53$52$20-$45